SAMJIN PHARMACEUTICAL CO.,LTD Logo

SAMJIN PHARMACEUTICAL CO.,LTD

Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.

005500 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Samjin Pharmaceutical Co., Ltd. is a Korean pharmaceutical company dedicated to the research, development, and manufacturing of treatments to improve human health. The company focuses on creating innovative therapies for diseases with high unmet medical needs, including cardiovascular, respiratory, and gastrointestinal disorders, with an ambition to become a global leader in the field. Through significant investment in R&D, Samjin has developed a diverse portfolio of both prescription and over-the-counter medications. Key products include the antiplatelet drug Plariss, the analgesic Geborin, and the hypercholesterolemia treatment Newstatin R. The company emphasizes securing technological competitiveness and building a robust pipeline of novel drugs.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SAMJIN PHARMACEUTICAL CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan 4553
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye TRILC
UCB Logo
UCB
Biopharma firm developing treatments for severe neurological and immunological diseases.
Belgium UCB
Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.
Hong Kong N/A
UNION KOREA PHARM CO.,Ltd Logo
Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.
South Korea 080720
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.
France VLA
Vaxcell-Bio Therapeutics Logo
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
South Korea 323990

Talk to a Data Expert

Have a question? We'll get back to you promptly.